More than 38 million aesthetic procedures were performed globally in 2024, including over 20 million non-surgical treatments such as lasers, peels and microneedling, with that figure widely expected to have increased further through 2025 and into 2026.

This is a more informed and more active consumer. Skin is being treated, monitored and managed with a level of precision that was previously confined to clinical settings. The products used in between those interventions are being selected with the same level of intent, supported by growing familiarity with both advanced treatments and high-performance formulations.

It is within this landscape that SkinCeuticals has built its position, operating at the intersection of clinical skincare and everyday use, where formulation strength and consistency of outcome carry greater weight than novelty. The celebrity-favourite brand operates within the dermatological beauty division of L’Oréal, with origins in antioxidant research led by Dr. Sheldon Pinnell at Duke University.

Skin assessment guided by clinical expertise, where diagnosis, treatment and product sit within the same moment, a model now reflected in SkinCeuticals’ Hainan experience.

getty

Travel retail, particularly in Asia, has evolved into a high-engagement environment for beauty, where time, spend and intent converge. Hainan has emerged as one of the most commercially significant examples of this shift.

Hainan operates as China’s duty-free hub, with individual annual allowances of up to RMB 100,000 (approximately £11,000) per shopper. That policy has concentrated premium beauty spend into a single geography, supported by China Duty Free Group, now the largest travel retailer globally.

Sanya and Haikou have become high-volume, high-value environments for skincare. Consumers arrive with intent, higher spending thresholds and time to engage, creating conditions where premium products convert more effectively than in traditional retail.

For brands, this is proximity to a consumer already in a purchasing mindset, already investing in wellness, and already open to higher-value categories.

Where Treatment, Diagnosis And Product Converge

SkinCeuticals’ collaboration with China Duty Free Group and Hydrafacial at The EDITION Sanya sits directly at the intersection of these dynamics. Clinical-grade skincare is placed inside a hotel environment, combining diagnostic tools, device-led treatments and product application within one setting.

AI-supported skin analysis and in-room or spa-based protocols bring consultation, treatment and recommendation into a continuous experience, rather than a series of separate steps. The point of decision sits closer to the moment skin is being actively assessed and treated.

Advanced RGN-6: Designed For Skin That Has Already Changed

Core SkinCeuticals formulations, led by SkinCeuticals C E Ferulic, continue to anchor routines through repeat use and clinical recommendation.

SkinCeuticals

That is where SkinCeuticals Advanced RGN-6 has made an immediate impact in its first year, sitting alongside the brand’s established formulations with a broad and loyal following.

Launched in 2025, the formulation was developed over five years to address visible changes that tend to appear in combination – redness, pigmentation, loss of firmness and textural irregularity. SkinCeuticals reports measurable improvement across these indicators, alongside accelerated barrier recovery and compatibility with laser-based treatments.

The formulation brings together niacinamide, peptides and ectoin within a system designed for skin that is reactive or recovering rather than stable. With the continued growth in aesthetic treatments, this reflects how skin is increasingly being managed between interventions.

New Pressures On Skin: Treatment Cycles And GLP-1 Impact

Aesthetic procedures alter skin in the short term, often leaving visible redness, sensitivity and disruption to the barrier. At the same time, the rise of GLP-1 weight loss treatments has introduced additional shifts in skin structure, particularly around elasticity and firmness, now widely discussed within clinical settings. (Photo by Steve Christo – Corbis/Corbis via Getty Images)

Corbis via Getty Images

Aesthetic procedures alter skin in the short term, often leaving visible redness, sensitivity and disruption to the barrier. At the same time, the rise of GLP-1 weight loss treatments has introduced additional shifts in skin structure, particularly around elasticity and firmness, now widely discussed within clinical settings.

Prescriptions for GLP-1 medications increased by more than 700% between 2019 and 2023, with UK usage continuing to rise sharply in the past year. These shifts are visible, immediate and increasingly common, shaping what consumers expect from the products they use next.

Brand Built On Formulations That Stay

Celebrity fans of SkinCeuticals: The product appears regularly within routines shared by figures including Hailey Bieber, Kendall Jenner and Sienna Miller, alongside continued use in clinical settings.

Getty Images

SkinCeuticals has built its position in areas where formulation strength is visible over time.

Products such as C E Ferulic continue to be used years after launch, supported by clinical recommendation and repeat consumer purchase. The formulation of 15% L-ascorbic acid, 1% vitamin E and 0.5% ferulic acid, remains one of the most referenced antioxidant combinations in dermatology-led skincare.

That consistency shows up across audiences time after time. The product appears regularly within routines shared by figures including Hailey Bieber, Kendall Jenner and Sienna Miller, alongside continued use in clinical settings.

Advanced RGN-6 extends that approach into the recovery phase of the skincare cycle.

The Convergence Of Retail, Treatment And Experience

The merging of retail and spa, supported by on-site expertise, real-time diagnosis and immediate prescription, brings treatment and product into the same moment.

SkinCeuticals

What is changing now is the environment in which these products are encountered. The merging of retail and spa, supported by on-site expertise, real-time diagnosis and immediate prescription, brings treatment and product into the same moment.

What sits underneath all of this is a shift in accountability. When skin has already been treated, already changed, already invested in, the product that follows is not being given the benefit of time. Time-pressured consumers expect performance in a way that is visible and repeatable, often within days. That is where loyalty is formed now, not at the point of discovery, but in the moments where something works well enough to be reached for again and again.